Monthly Archives: September 2014

GM recalling cars

120515_gm_ap

General Motors is facing defect problem right now.

GM has been recalling cars since last winter due to its defection. Now, it is retrieving another 40,000 cars around the world. And its product, Impala, was recalled due to MANY DEFECTIONS like transmission defect, ignition and joint problem. It’s not a surprise that the national institution, NHTSA, required investigations into the quality of the cars by GM.

I came up with some suggestions under this circumstance. Firstly, they should focus more on the inspection part of the cars. Products have to meet PoP of the industry to get itself into the game. However, GM failed to achieve even PoP in quality. Besides, they also need to develop better customer relations and wider channels. These parts became especially useful when GM might want to take responsibility of there mistake. Good customer relations keep consumers trust even after the defection and broad channel grants GM a chance to win customers back.

GM, survived through government bailout in 2009, should find its own approach to regain population instead of relying merely on the fund it has. Neither should its glorious history stiffen it from producing better(meeting PoP) and more innovative(with PoD) products.
Picture Source: http://www.politico.com/news/stories/0512/76349.html

Reference:

Kessler, Aaron “GM recalls Impalas and Cadillacs Over Risk of Brake Fire” www.nytimes.com <http://www.nytimes.com/2014/09/21/business/gm-recalls-impalas-and-cadillacs-over-risk-of-brake-fires.html?mabReward=RI%3A12&action=click&pgtype=Homepage&region=CColumn&module=Recommendation&src=rechp&WT.nav=RecEngine&_r=0> Sep 20, 2014

“GM made $22.6 billion, we lost $10.6 billion”<http://money.cnn.com/2014/05/29/news/companies/gm-profit-bailout/> CNN,  May 29, 2014

Cubbon, Paul”Intro to Positioning and Value Propositions”(video) <http://vimeo.com/49370591> posted on course prep

An Analysis to Mathew Martoma’s Insider Trading(Class 3)

0908_mathew-martoma_1024x576

Mathew Martoma, once working in a fund firm, got a nine year sentence on Monday for insider trading. Earlier this year,  Martoma was found guilty of trading the information about a drug, for $200-million dollar profit for his company and $9-million for his own.

Homo economicus tends to act out of self-interest and Martoma should not be an exception. Due to business nature, we have to guess what others will be doing in order to be success. During the process of guessing, the market failed to reached its equitability between the own interest and morality of Martoma, which caused the action of moral deficiency- insider trading. He, as the first moral actor, got a nine-year-sentence. And his former company, SAC, (second moral actor) also paid over $6 million for this.

I suppose he should have found the balance between his own self-interest and business ethics, with which everyone should comply. Had he not committed insider trading, he shouldn’t have gained such a long sentence.

 

Picture from: http://www.forbes.com/sites/nathanvardi/2014/09/08/mathew-martoma-sentenced-to-nine-years-for-insider-trading/

Reference

Vardi, Nathan “Mathew Martoma Sentenced to nine years for insider trading” www.forbes.com <http://www.forbes.com/sites/nathanvardi/2014/09/08/mathew-martoma-sentenced-to-nine-years-for-insider-trading/> Sep 8, 2014

Parkin, Michael & Bade, Robin “MICROECONOMICS, CANADA IN THE FLOBAL ENVIRONMENT” Eighth Edition